Marginal Zone Lymphoma (MZL)

specific

A B-cell non-Hodgkin lymphoma composed of small lymphocytes which surround and replace the splenic white pulp germinal centers. It involves the spleen and splenic hilar lymph nodes, bone marrow, and often the peripheral blood. When lymphoma cells are present in the peripheral blood, they are usually, but not always, characterized by the presence of short polar villi. (WHO)

27

Centers

33

Active Trials

$3M

Cancer Funding

Top Centers for Marginal Zone Lymphoma (MZL)(27)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.2
2
NCI Comprehensive
High-Volume Research Center
71.2
3
High-Volume Research Center
71.2
4
NCI Comprehensive
Active Research Program
65.4
5
Active Research Program
65.4
6
Active Research Program
65.4
7
Active Research Program
65.4
849.5
9
NCI Comprehensive
Active Research Program
48.7
10
NCI Comprehensive
Active Research Program
48.7
11
NCI Comprehensive
Active Research Program
48.7
12
NCI Comprehensive
Active Research Program
48.7
13
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
48.7
14
NCI Comprehensive
Active Research Program
48.7
15
NCI Comprehensive
Active Research Program
48.7
16
NCI Comprehensive
Active Research Program
48.7
17
NCI Comprehensive
Active Research Program
48.7
18
NCI Clinical
Active Research Program
48.7
19
NCI Comprehensive
Active Research Program
48.7
20
Active Research Program
48.7
21
NCI Clinical
Active Research Program
48.7
22
NCI Comprehensive
Active Research Program
48.7
23
Active Research Program
48.7
24
Active Research Program
48.7
25
NCI Comprehensive
32.0
26
NCI Comprehensive
32.0
2732.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →